menu
    • menu

    Company profile for K36 Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics.KTX-1001 is an orally bioavailable small molecule and a selective inhibitor of MMSET, which is overexpressed in up to 20% of multiple myeloma patients due to a t(4;14) translocation. We are develo...
    K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics.KTX-1001 is an orally bioavailable small molecule and a selective inhibitor of MMSET, which is overexpressed in up to 20% of multiple myeloma patients due to a t(4;14) translocation. We are developing KTX-1001 to provide a targeted therapy that specifically addresses the underlying cause of cancer for these multiple myeloma patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    K36 TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 Main Street Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.k36tx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/k36-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    K36 Therapeutics Unveils KTX-2001 Prostate Cancer Study Design
    K36 Therapeutics Unveils KTX-2001 Prostate Cancer Study Design

    24 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/k36-therapeutics-highlights-first-in-human-ktx-2001-prostate-cancer-study-design-at-american-society-of-clinical-oncology-asco-genitourinary-cancers-symposium-2026-302695037.html

    PR NEWSWIRE
    24 Feb 2026
    Share Share
    K36 Therapeutics Completes KTX-2001 Dosing for Prostate Cancer
    K36 Therapeutics Completes KTX-2001 Dosing for Prostate Cancer

    05 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/k36-therapeutics-completes-dosing-of-first-cohort-in-phase-1-clinical-trial-of-ktx-2001-in-prostate-cancer-announces-new-cmo-302680429.html

    PR NEWSWIRE
    05 Feb 2026
    Share Share
    K36 Therapeutics Presents First Human Data On Gintemetostat
    K36 Therapeutics Presents First Human Data On Gintemetostat

    05 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/k36-therapeutics-announces-presentation-of-first-in-human-clinical-data-for-gintemetostat-ktx-1001-demonstrating-target-engagement-and-clinical-activity-in-multiple-myeloma-at-ash-2025-and-the-appointment-of-dr-shinta-cheng-m-302633778.html

    PR NEWSWIRE
    05 Dec 2025
    Share Share
    K36 Therapeutics Showcases Preclinical Data for KTX-1001 Phase 1
    K36 Therapeutics Showcases Preclinical Data for KTX-1001 Phase 1

    18 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/k36-therapeutics-to-present-new-preclinical-data-supporting-ongoing-phase-1-clinical-trial-of-ktx-1001-at-the-22nd-annual-international-myeloma-society-meeting-302558270.html

    PR NEWSWIRE
    18 Sep 2025
    Share Share
    FDA clears K36 Therapeutics' IND for KTX-2001 in mCRPC Cancer
    FDA clears K36 Therapeutics' IND for KTX-2001 in mCRPC Cancer

    08 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/k36-therapeutics-receives-fda-clearance-of-investigational-new-drug-ind-application-for-ktx-2001-in-metastatic-castration-resistant-prostate-cancer-mcrpc-and-announces-clinical-trial-collaboration-with-bayer-for-supply-of-daro-302523702.html

    PR NEWSWIRE
    08 Aug 2025
    Share Share
    K36 Therapeutics Announces Appointment of Benjamin Winograd as CMO
    K36 Therapeutics Announces Appointment of Benjamin Winograd as CMO

    15 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/k36-therapeutics-announces-appointment-of-benjamin-winograd-md-phd-as-chief-medical-officer-301988421.html

    PR NEWSWIRE
    15 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search